Valuation: Zentiva,

Market Cap 243M 212M 200M 181M 340M 23.3B 341M 2.39B 923M 11.85B 913M 893M 38.12B P/E 2017
7.27x
P/E 2018 177x
Enterprise Value 242M 211M 199M 181M 339M 23.23B 340M 2.38B 920M 11.81B 910M 890M 38B EV / Sales 2017
3.97x
EV / Sales 2018 11.2x
Free-Float
4.05%
Yield 2017
13.8%
Yield 2018 -
6 months+3.33%
Current year+3.33%
1 month 31
Extreme 31
31
Current year 29
Extreme 29
33
1 year 29
Extreme 29
45
3 years 24
Extreme 24
45
5 years 24
Extreme 24
45
10 years 11
Extreme 11
370
Manager TitleAgeSince
Chief Executive Officer - 2015-11-11
Corporate Officer/Principal - 2022-08-17
Director TitleAgeSince
Director/Board Member - 2013-07-07
Director/Board Member - 2018-10-17
Director/Board Member 58 2020-11-14
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-31.11%+3.33% 57.6M
-1.61%-0.15%+11.45%+60.09% 45.94B
-1.02%-1.90%+35.99%+100.50% 37.22B
+2.19%+3.65%+10.70%+80.29% 12.06B
+1.32%+2.09%-11.64%+12.41% 11.74B
-0.95%0.00%+18.72%+150.00% 9.03B
+0.39%+2.39%+29.99%+38.63% 7.36B
-0.06%+2.97%+38.90%-18.67% 7.15B
+1.30%+1.17%+16.08%+187.41% 7.2B
+0.70%+1.10%-44.22%+5.78% 5.03B
Average +0.23%+0.98%+7.49%+61.98% 14.28B
Weighted average by Cap. -0.44%+0.23%+16.93%+73.53%

Financials

2017 2018
Net sales 143M 124M 117M 107M 200M 13.68B 200M 1.4B 542M 6.96B 536M 524M 22.38B 36.17M 31.49M 29.73M 27.01M 50.6M 3.47B 50.83M 356M 137M 1.76B 136M 133M 5.67B
Net income 77.98M 67.89M 64.08M 58.22M 109M 7.48B 110M 766M 296M 3.8B 293M 286M 12.23B 2.29M 1.99M 1.88M 1.71M 3.2M 220M 3.22M 22.51M 8.69M 112M 8.6M 8.41M 359M
Net Debt -0.09 -0.08 -0.08 -0.07 -0.13 -8.82 -0.13 -0.9 -0.35 -4.49 -0.35 -0.34 -14.43 -0.77 -0.67 -0.64 -0.58 -1.08 -74.21 -1.09 -7.61 -2.94 -37.74 -2.91 -2.84 -121.41
Logo Zentiva,
Zentiva as is a Slovakia-based company engaged in generic pharmaceuticals business sector. The Company develops, manufactures, and sells generic medicinal products, primarily used in primary care sector. Its portfolio includes preparations for various therapeutic areas, including cardiovascular system, women’s healthcare, respiratory system, antimicrobials, urological system, central nervous system, pain, and gastrointestinal system.
Employees
90
  1. Stock Market
  2. Stocks
  3. 1SKF401E Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!